In addition, whereas normal colonic epithelial cells are dependent on BCL2, there is a shift in the intestinal adenoma phase to BCL-xL, thus, BCL-xL inhibitors are suggested to have a more profound effect in CRC [22]. Here, BCL2L1 is linked to adenoma.